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A B S T R A C T
Purpose: To investigate the frequency and patterns of headache in a well-deﬁned and homogeneous
group of mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) patients.
Methods: One hundred consecutive MTLE-HS patients under comprehensive presurgical evaluation
were evaluated fromMay 2009 to April 2010. A standardized questionnaire was applied according to the
criteria of the International Headache Society (IHS). Headache diagnosis was based on the second edition
of the International Classiﬁcation of Headache Disorders (ICHD-II).
Results: Ninety-two patients (92%) had at least one headache episode during the previous 12 months.
Migraine occurred in 51.9% of patients and tension-type headache (TTH) in 39.1%. Patients withmigraine
presented higher frequency (p = 0.002) and severity of episodes (p < 0.001), as well as lateralized pain
(p = 0.001) than individuals with TTH. MTLE-HS patients with unilateral HS and predominantly
unilateral headache (irrespective of the type), presented pain ipsilateral to the HS (OR 8.5; CI 95% = 2.1–
35.1; p = 0.003).
Conclusions: Headache is a frequent clinical symptom of lateralizing value, which may share common
pathophysiology with epileptogenesis among MTLE-HS patients.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.1. Introduction
Epilepsy is a chronic condition that causes great impact in
patient’s quality of life and on the health care budget. Its
prevalence is approximately 0.5–1% in general population.1 In
developing countries, the incidence and prevalence rates are
higher due to the high proportion of young individuals and their
hygiene and public health conditions.2 Twenty percent of the
epilepsies are medically intractable and mesial temporal lobe
epilepsy with hippocampal sclerosis (MTLE-HS) has been recog-
nized as a well-deﬁned surgically remediable epileptic syn-
drome.3–5 The adequate selection of these patients for surgery
depends on the concordance of clinical, neuroimaging and
electroencephalographic (EEG) data.4* Corresponding author at: Departamento de Clı´nica Me´dica, Hospital Uni-
versita´rio (HU), Universidade Federal de Santa Catarina (UFSC), Campus Uni-
versita´rio, Trindade, Floriano´polis, SC 88040-970, Brazil. Tel.: +55 4837219149;
fax: +55 4837219014.
E-mail address: linkatia@uol.com.br (K. Lin).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.02.014Few abnormalities may be found on general neurologic
interview and examination other than the seizures among
MTLE-HS patients, as facial asymmetry with lower facial weakness
contralateral to HS.6 These symptoms or signs may be a clinically
useful clue that may assist in lateralizing the site of seizure onset,
aiding in the presurgical selection of these patients.
The association between epilepsy and headache is still poorly
understood although it has been recognized for a long time.7 Both
migraine and epilepsy are chronic neurological disorders mani-
fested as paroxysmal episodes of transient brain dysfunction with
clinical characteristic symptoms often including gastrointestinal
and autonomic manifestations, postictal lethargy, altered level of
consciousness, visual disturbances, hormonal involvement, dizzi-
ness, numbness, hemiparesis and aphasia.7–9 Welch et al.10
proposed that an altered excitability status of occipital cortex
may be an important pathogenic factor for migraine, probably
lowering the threshold for the development of cortical spreading
depression (CSD). Moreover, experimentally induced CSD in
human neocortical slices was able to induce sharp potentials,11
representing a possible link between migraine and epilepsy.vier Ltd. All rights reserved.
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ing value of headache in a well-deﬁned and homogeneous group of
MTLE-HS patients.
2. Methods
This was an observational, cross-sectional and analytic study.
From May 2009 to April 2010, we interviewed all MTLE-HS patients
undergoing presurgical evaluation in Centro de Epilepsia de Santa
Catarina (CEPESC), Floriano´polis, SC, Brazil, due to refractory epilepsy.
The comprehensive presurgical evaluation consisted of a
detailed clinical history, neurologic examination, cerebral 1.5 T
magnetic resonance imaging (MRI), neuropsychological and
psychiatric studies, and psychosocial assessments. Patients also
underwent 2–6 days of continuous video-EEGmonitoringwith 32-
channel EEG recording, with electrodes placed according to 10–10
system on the temporal lobes. All patients had clear MRI ﬁndings
consistent with HS and concordant interictal and ictal EEG data.
Hippocampal sclerosis was deﬁned if atrophy, an increased T2-
weighted signal, a decreased T1-weighted signal, and disrupted
internal structure of the hippocampus were present on visual
inspection of MRI pictures.12–14 The epileptogenic zone was
determined by predominantly ipsilateral interictal epileptic
abnormalities (70% cutoff) and unequivocal unilateral seizure
onset recorded during prolonged video-EEG monitoring.
Clinical features were recorded according to a speciﬁc protocol
developed for this study. Patients’ previous medical charts were
also reviewed. The exclusion criteria15–17 were: (1) focal neuro-
logical abnormalities on physical examination suggesting a
constellation other than MTLE-HS; (2) generalized or extra-
temporal EEG spikes; (3) marked cognitive impairment on
neuropsychological testing suggesting a more widespread disease
other than MTLE-HS and subject to compromising the interview.
A standardized questionnaire was applied according to the
criteria of the International Headache Society (IHS) by one
researcher (DBZ) blinded for all the clinical, radiological and
EEG data of patients. Ten percent of these interviews were also
applied in the same patient by the ﬁrst author (JCN) to assure the
reproducibility of the questionnaire. Headache diagnosis was
made by a board certiﬁed neurologist (JCN) based on the secondTable 1
Clinical variables of MTLE-HS patients with and without headache.
Variables All
Patients n=100 (%)
Gendera
Man 45 (45%)
Woman 55 (55%)
Age (years)b
Median (IQ range 25–75) 38 (29–45)
Education (years)b
Median (IQ range 25–75) 7 (4–10)
Age at ﬁrst epileptic seizure (yo)b
Median (IQ range 25–75) 4 (1.1–12)
Age at epilepsy onset (yo)b
Median (IQ range 25–75) 12 (7–18)
Duration of epilepsy (years)b
Median (IQ range 25–75) 24 (15–31)
Frequency of seizures (month)b
Median (IQ range 25–75) 3.5 (2–12)
Hippocampal sclerosisa
Left 46 (46%)
Right 46 (46%)
Bilateral 8 (8%)
IQ 25–75= interquartile range 25% and 75%; MTLE-HS=mesial temporal lobe epilepsy
a Fisher’s exact test.
b Mann–Whitney U-test.edition of the International Classiﬁcation of Headache Disorders
(ICHD-II),18 according to the headache episodes presented in the
previous year. Patients were divided into two groups: (1) migraine
patients and (2) tension-type headache (TTH) patients. The
headache diagnosis was blinded for all the clinical, radiological
and EEG data related to the epileptic syndrome including the MRI
ﬁndings.
Clinical and demographic characteristics included age, gender
and schooling. The use of sodium valproate was also controlled
due to its effect on headache prophylaxis. Regarding headaches,
the following features were analyzed: presence of headache
episodes in lifetime and in the previous year; frequency; age of
onset; pattern; predominant side; severity (assessed using an
analogical scale: 0–10; 0, no pain and 10, worst possible pain);
duration; associated symptoms and symptomatic medicines used
during the events. For those patients presenting more than one
type of headache, the most severe and troublesome type was taken
into consideration for this study. According to the temporal
relation between headaches and seizures, headache was classiﬁed
as interictal (non-temporal relation) and peri-ictal (well-estab-
lished temporal association). Some patients referred both, but the
peri-ictal type was the only one considered for the analysis of its
lateralizing value in relation to HS.
This study was approved by the Ethics Committee on Human’s
Research of our hospital and informed consent was obtained from
all patients.
2.1. Statistical analysis
Statistical analysis was performed using the SPSS for Windows
17.0 (SPSS Inc., Chicago, IL, USA).
Categorical variables were analyzed by Fisher’s exact test.
Continuous variables were analyzed by Student’s t-test (paramet-
ric distribution) or Mann–Whitney U-test (non-parametric distri-
bution) accordingly. Posteriorly, continuous variables were
categorized in order to allow analysis of the association between
the headache type and clinical, demographic and neuroimaging
variables by binary logistic regression. Also, the association
between the side of HS and unilateral headache was analyzed
by binary multiple logistic regression.Presence of headache
Positive n=92 (%) Negative n=8 (%) p
42 (45.7%) 3 (37.5%) 0.73
50 (54.3%) 5 (62.5%)
38 (29–45.7) 36 (23.7–43) 0.40
7(4–10) 5.5 (3.2–10.5) 0.39
4 (1–12) 10 (5.3–18.9) 0.32
12 (6–18) 16.5 (15.2–19.5) 0.12
24 (15–32) 19 (13–24.7) 0.19
3 (1.2–11.5) 5 (2.2–11.5) 0.53
43 (46.7%) 3 (37.5%) 0.51
41 (44.6%) 5 (62.5%)
8 (8.7%) 0 (0%)
with hippocampal sclerosis; yo=years-old.
Table 2
Clinical, demographic and neuroimaging patterns according to headache type of MTLE-HS patients.
Variables Headache n=92 (%) Migraine n=56 (51.9%) TTH n=36 (39.1%) Crude Odds Ratio (CI 95%) p
Age of onsetb
Median (SD) 16.4 (5.6–27.2) 16.4 (5.6–27.2) 16.3 (5.4–27.2) N.A. 0.95
Headache frequencya
Annual or monthly 23 (25) 7 (12.5) 16 (44.4) 1.0
2–14days per month 47 (51) 33 (58.9) 14 (38.9) 5.4 (1.8–16) 0.002*
15days per month 22 (23) 16 (28.6) 6 (16.7) 6.1 (1.7–22.2) 0.006*
Duration of headachea
<1h 9 (9.8) 3 (5.4) 3 (10) 1.0
1–3h 27 (29.3) 11 (19.6) 14 (46.7) 1.4 (0.3–6.7) 0.69
4–12h 14 (15.2) 8 (14.3) 6 (20.0) 2.7 (0.5–15.3) 0.27
13–24h 25 (27.2) 20 (35.7) 4 (13.3) 8 (1.5–43.7) 0.01*
>24h 17 (18.5) 14 (25) 3 (10.0) 9.3 (1.4–60.2) 0.02*
Headache severityb
Median (SD) 7.6 (5.4–9.8) 8.4 (6.8–10) 6.2 (3.9–8.5) N.A. <0.001*
Side of headachea
Bilateral 46 (50.0) 18 (32.1) 28 (77.8) 1.0
Left 24 (26.1) 20 (35.7) 4 (11.1) 7.8 (2.3–26.5) 0.001*
Right 22 (23.9) 18 (32.1) 4 (11.1) 7 (2.0–24.1) 0.002*
Side of HSa
Bilateral 8 (8.7) 5 (8.9) 3 (8.3) 1.0
Left 43 (46.7) 29 (51.8) 14 (38.9) 1.2 (0.2–5.9) 0.79
Right 41 (44.6) 22 (39.3) 19 (52.8) 0.7 (0.1–3.3) 0.65
Headache and seizuresa
Interictal headache 20 (21.7) 7 (12.5) 13 (36.1) 1.0
Peri-ictal headache 72 (78.3) 49 (87.5) 23 (63.9) 3.9 (1.4–11.2) 0.01*
Sodium valproate treatmenta
No 73 (79.3) 46 (82.1) 27 (25) 1.0
Yes 19 (20.7) 10 (17.9) 9 (75) 0.6 (0.2–2.1) 0.45
CI = conﬁdence interval; HS=hippocampal sclerosis;MTLE-HS=mesial temporal lobe epilepsywith hippocampal sclerosis; NA=not applicable; TTH= tension-type headache.
a Binary logistic regression.
b Student’s t-test.
* Statistically signiﬁcant at p<0.01.
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recurrent seizures) and the age of headache onset was analyzed by
simple linear regression.
The ‘‘p’’ levels lower than 0.01 were considered signiﬁcant. This
more stringent criterion for the ‘‘p’’ level of signiﬁcance was based
on the Bonferroni adjustment for multiple tests.19
3. Results
A hundred consecutive patients were interviewed. Their
median age was 38 (29–45) years and 55 (55%) were female.
Clinical and demographic variables according to the presence of
headache are demonstrated in Table 1. Headache episodes were
referred by 92 (92%) of all patients and they were classiﬁed
according to ICHD-II.18 There were no statistical differences
concerning gender, age of ﬁrst epileptic seizure, frequency of
seizures and MRI ﬁndings between patients with and without
headache (p > 0.32). There was a non-signiﬁcant trend for lower
age of epilepsy onset (p = 0.12) and longer duration of epilepsy
(p = 0.19) among patients presenting headache.Table 3
Association between the predominant side of headache and the side of the HS.
Patients Side of hippocampal scleros
Variables Headache n=42 (%) Left n=24 (51%)
Predominant side of headachea
Right 21 (25) 7 (16.3)
Left 21 (25) 17 (39.5)
Classiﬁcation of headachea
Tensional 33 (39) 14 (32.6)
Migraine 51 (61) 29 (67.4)
CI = conﬁdence interval.
a Binary logistic regression.
* Statistically signiﬁcant at p<0.01.The most frequent diagnosis was migraine without aura in 24
patients (24%) followed by probable migraine in 19 (19%).
Furthermore, infrequent episodic TTH was diagnosed in 15
(15%) and migrainous-type chronic daily headache (CDH) in 8
(8%) patients.
The association among the type of headache, clinical, demo-
graphic and neuroimaging data as well as headache severity and
frequency are presented in Table 2. The Crude Odds Ratio indicates
the level of association between the analyzed variables and
migrainous headache. Migraine occurred in 51.9% while TTH in
39.1% patients. As expected, patients with migraine had higher
frequency (p < 0.006), duration (p < 0.02), severity (p < 0.001) and
lateralized pain (p < 0.002) than TTH ones. In comparison to
interictal headache, peri-ictal headache was 3.9 times more
associated to migraine than TTH (OR 3.9; CI 95% 1.4–11.2;
p = 0.01). There were no statistical differences concerning the
age of epilepsy onset (p = 0.95), HS side (p > 0.65) and treatment
with sodium valproate (p = 0.45) between migranous and TTH
patients. Patients with annual–monthly headache episodes pre-
sented 2 seizures/month [IQ(25–75) = 2–3], while patients with 2–is Crude Odds Ratio (CI 95%)
Right n=18 (49%) p
14 (34.1) 1.0
4 (9.8) 8.5 (2.1–35.1) 0.003*
19 (46.3) 1.0
22 (53.7) 1.6 (0.3–9.5) 0.61
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75) = 2–12] and 8 [IQ(25–75) = 2–16] seizures/month respectively
(p < 0.01), suggesting a positive association between the frequency
of seizures and headache episodes.
Among the 42 patients with predominantly unilateral headache
and unilateral HS, the headachewas ipsilateral to HS in 31 patients
(17 left and 14 right). Patients with headache occurring
predominantly on the left side was 8 times more associated with
left HS in comparison to the right HS (OR 8.5; CI 95% 2.1–35.1;
p = 0.003) irrespectively to the headache type (Table 3).
4. Discussion
This study showed a higher prevalence of headache among
MTLE-HS patients (92%) in comparison to the 80.8% in the general
population of our city previously reported in an epidemiological
study.20
Other studies have attempted to demonstrate an association
between epilepsy and headaches. Headache episodes were
associated with the occurrence of seizures in 15–62% of patients
with epilepsy, in which 55% were of migrainous-type and 37%
tension-type, being 34–60% exclusively peri-ictal.21–24 Our preva-
lence was higher than previously reported, probably related to
higher frequency of seizures and duration/severity of epilepsy of
our patient population, selected from a tertiary health care center.
Among patients with unilateral HS, we evidenced a signiﬁ-
cant association between the predominant side of headache and
the side of HS. Our ﬁndings are in agreement with other studies,
which demonstrated association between the headache laterali-
zation and seizure onset zone in patients with temporal lobe
epilepsy.25 Our study also provided evidence for the possible
relation between headache and epilepsy by demonstrating the
temporal association between the seizure frequency and
headache episodes.
Our ﬁndingsmay have implications in the current knowledge of
the headache pathophysiology. Despite the fact that the associa-
tion between epilepsy and headache has already been discussed
for many years, its pathophysiology remains obscure. There seems
to be an agreement regarding the side of headache and HS, which
would suggest a common underlying brain dysfunction. In fact, the
most frequently accepted mechanism for the relation between
vascular and neuronal function in migraine aura is the CSD
described by Lea˜o.26 CSD consists of a wave of cortical hyper-
arousal followed by an inhibitory wave, which is evidenced by the
reduction of 15–53% of cerebral blood ﬂow during visual auras in
occipital cortex contralateral to the affected visual ﬁeld. Interest-
ingly, only one of our patients presented migraine with aura. After
the binary multiple logistic regression analysis we demonstrated
an association between the HS and predominant headache side
which remained signiﬁcant, independently of the type of headache
(migraine  TTH). The epilepsy surgery enables the direct visuali-
zation of cortical vessel vasodilation during an epileptic attack. It
has also been extensively documented by ictal Single Photon
Emission Computed Tomography (SPECT).27 Nitric oxide (NO) is
involved in the regulation of basal cerebral circulation during
hypercapnia, neuronal activation and ictal brain vasodilation.28
The NO is an important neurotransmitter in the glutamatergic
excitatory synapses29 which may be the common link related with
the neuronal hyperactivity and brain hyperperfusion during
epileptic seizures and headache episodes.30
There are some limitations that need to be acknowledged
regarding the present study. The ﬁrst one concerns the cross-
sectional design and the second one concerns the frequency of
headache episodes, which was based on retrospective recall by the
patient. We tried to avoid this recall bias by taking into account
only the headache episodes occurred within the last year.Furthermore, the ﬁndings in our study may not be applied to all
epilepsy patients due to the fact that it included only refractory
patients from a tertiary health care center.
In conclusion, physicians should be familiar with the principles
of the diagnosis and treatment of both epilepsy and headache.
Speciﬁc strategiesmust be applied to both comorbidities once they
are often seen in association. Further prospective, placebo-
controlled, double-blind and randomized studies are required to
determine the best therapeutic strategy to treat headache in
patients with epilepsy.
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